BGT vs OSL

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

41LOW

OSL

ONCOSIL FPO [OSL]

41LOW

Score Breakdown

BGT OSL
Technical
46
37
Catalyst
50
62
Sentiment
50
50
Fundamental
44
60
Momentum
42
50
Risk Gate
24
50

Key Metrics

BGT Metric OSL
$6.6MMarket Cap$35.5M
607KAvg Volume (20d)290K
N/AShort InterestN/A
$0.06152-Week High$2.090
$0.01652-Week Low$0.370
+0.0%Daily Change-8.7%
$0.017Reference Price$1.150
-202.2%ROE-208.4%
N/AProfit MarginN/A

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

OSL Signals

MACD crossed bearish — momentum is fading
Watch out — volume is flowing out even as price holds up. Distribution pattern
Took a hit — down 22.3% over the last 5 days
Beating the Small Ords index — relative strength of 2.06, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (0.9 quarters)
Moderate P/S ratio (9.5x)
Strong revenue growth (+222%)

Ask Scout AI to compare BGT and OSL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs EIQ →EIQ vs MEM →EIQ vs VHL →DXB vs MEM →DXB vs VHL →
BGT Full Analysis → OSL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).